Browse Studies — Arctuva

Observational

StableEyes With Active Neurophysiological Feedback

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness…

Vestibular DisorderVestibular SchwannomaSpace Motion Sickness+1 more

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT05622344

Phase 2

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwa…

Neurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+2 more

Estimated

~$10 – $7,500

Scott R. Plotkin, MD, PhDNCT04374305

Observational

Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas

The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patien…

Vestibular Schwannoma

Estimated

~$10 – $6,250

Medical College of WisconsinNCT05702749

Phase 1

A Phase 1/2 Trial of AAVAnc80-antiVEGF Gene Therapy in Individuals With Unilateral Vestibular Schwannoma

This trial will evaluate the safety and tolerability of a single unilateral administration of one of three dose levels of AAVAnc80-antiVEGF and will evaluate t…

Vestibular Schwannoma

Estimated

~$10 – $8,750

Akouos, Inc.NCT06517888